Related Experiment Video
Updated: Jun 12, 2025
Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Gut microbiota and renal fibrosis
Yinghao Tong1, Shangze Guo1, Ting Li1
1School of Basic Medical Sciences, Shandong Second Medical University, Weifang, China.
Abstract:
Renal fibrosis represents a critical pathological condition in the progression of renal dysfunction, characterized by aberrant accumulation of extracellular matrix (ECM) and structural alterations in renal tissue. Recent research has highlighted the potential significance of gut microbiota and demonstrated their influence on host health and disease mechanisms through the production of bioactive metabolites. This review examines the role of alterations in gut microbial composition and their metabolites in the pathophysiological processes underlying renal fibrosis. It delineates current therapeutic interventions aimed at modulating gut microbiota composition, encompassing dietary modifications, pharmacological approaches, and probiotic supplementation, while evaluating their efficacy in mitigating renal fibrosis. Through a comprehensive analysis of current research findings, this review enhances our understanding of the bidirectional interaction between gut microbiota and renal fibrosis, establishing a theoretical foundation for future research directions and potential clinical applications in this domain.
Insights
Gut microbiota alterations contribute to kidney fibrosis by producing bioactive metabolites. This review explores microbial roles and therapies like diet and probiotics for mitigating renal fibrosis.
Area of Science:
- Nephrology
- Microbiology
- Gastroenterology
Background:
- Renal fibrosis is a key factor in progressive kidney dysfunction, marked by extracellular matrix accumulation.
- Gut microbiota influence host health and disease via bioactive metabolites.
- Emerging evidence links gut microbiota dysbiosis to renal fibrosis pathogenesis.
Purpose of the Study:
- To review the role of gut microbiota and their metabolites in renal fibrosis.
- To examine therapeutic strategies targeting gut microbiota for renal fibrosis.
- To elucidate the bidirectional relationship between gut microbiota and renal fibrosis.
Main Methods:
- Literature review of current research on gut microbiota and renal fibrosis.
- Analysis of studies on dietary, pharmacological, and probiotic interventions.
- Evaluation of the efficacy of microbiota-modulating therapies.
Main Results:
- Alterations in gut microbial composition are implicated in renal fibrosis.
- Bioactive metabolites produced by gut microbes can influence renal tissue.
- Therapeutic interventions show potential in mitigating renal fibrosis.
Conclusions:
- Gut microbiota play a significant role in the development and progression of renal fibrosis.
- Modulating gut microbiota offers a promising therapeutic avenue for kidney disease.
- Further research is needed to establish clinical applications for microbiota-based therapies.
Related Concept Videos
01:20Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...